RecruitingNCT07122531
About this title
Recovery With Exogenous Ketones and Antipsychotics
Read the official source — NCT07122531Official study titleMetabolic and Clinical Evaluation of Medium-Chain Triglyceride-Based Exogenous Ketone Supplementation as an Adjunctive Treatment for First-Episode Psychosis
In SherbrookeSchizophreniaInterventional studyAges 18–35
- Countries
- Canada
- Sponsor
- Université de Sherbrooke
RecruitingNCT07569471
In Scarborough VillageSchizophreniaInterventional studyAges 18+
- Countries
- Canada
- Sponsor
- University of Toronto
RecruitingNCT07397975
Official study titleA Prospective Multicenter Study for Relapse Risk Assessment Through Language Analysis in Individuals With Psychosis
In ZurichSchizophreniaObservational studyAges 18–65
- Countries
- Switzerland, Czechia, Ireland, + 3 others
- Sponsor
- Philipp Homan
RecruitingNCT06778564
About this title
Stratification and Treatment in Early Psychosis Study - ENHANCE
Read the official source — NCT06778564Official study titleAugmentation With Cannabidiol in First Episode Psychosis: a Double-blind, Randomised Controlled Trial
Multiple locations, including CambridgeSchizophreniaMedication studyAges 16–40
- Countries
- United Kingdom, Switzerland, Austria, + 6 others
- Sponsor
- University of Oxford (University)
RecruitingNCT06651112
About this title
The ATP Project (Antipsychotic-TEP-Psychosis)
Read the official source — NCT06651112Official study titleImpacts of Psychosis and Antipsychotics on Cerebral Energy Metabolism: the ATP Project (Antipsychotic-TEP-Psychosis)
In SherbrookeSchizophreniaObservational studyAges 18–35
- Countries
- Canada
- Sponsor
- Université de Sherbrooke
Not Yet RecruitingNCT06977308
This study isn't recruiting yet.
Location not clearly listedSchizophreniaMedication studyAges 18–30
- Countries
- Sponsor
- New York State Psychiatric Institute
Not Yet RecruitingNCT06546475
Official study titleTapering Antipsychotics in Patients With Remitted Psychosis: From Bedside to Bench Employing Animal Model and N-Acetylcysteine Study and Back to Bedside
This study isn't recruiting yet.
Location not clearly listedSchizophreniaMedication studyAges 18–60
- Countries
- Sponsor
- National Taiwan University Hospital
Not Yet RecruitingNCT06042712
Official study titleBelief-updating and Speech: Potential Markers of Psychosis Relapse
This study isn't recruiting yet.
Location not clearly listedSchizophreniaObservational studyAges 18–40
- Countries
- Sponsor
- King's College London (University)
Not Yet RecruitingNCT07623928
Official study titleMANaging emOtions in Everyday Life Using Virtual REality (MANOEUVRE): Developing a VR-assisted Intervention for Emotion Regulation Difficulties in Psychosis
This study isn't recruiting yet.
In LondonSchizophreniaInterventional studyAges 18+
- Countries
- United Kingdom
- Sponsor
- King's College London (University)
Not Yet RecruitingNCT07628699
Official study titleDigital Heart Rate Variability Biofeedback Intervention for First Episode Psychosis: A Randomized Controlled Trial
This study isn't recruiting yet.
In Hong KongSchizophreniaBehavioural studyAges 18–55
- Countries
- China
- Sponsor
- The University of Hong Kong
Not Yet RecruitingNCT07252752
Official study titleDopamine and Insulin in Psychosis: Imaging the Effects of Intranasal Insulin on Dopamine Transmission
This study isn't recruiting yet.
In ViennaSchizophreniaMedication studyAges 18–40
- Countries
- Austria
- Sponsor
- Medical University of Vienna
Not Yet RecruitingNCT07129369
Official study titleEvaluating the Effects of a Peer-facilitated, Acceptance-based Self-learning for Illness Management (PASIM) Program for Adults With Recent-onset Psychosis: A Randomized Controlled Trial
This study isn't recruiting yet.
In Hong KongSchizophreniaBehavioural studyAges 18–64
- Countries
- China
- Sponsor
- Chinese University of Hong Kong